News

News & Reports 2018-03-22T10:04:39+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

$10.7 BILLION: MORE BIOTECH FIRMS, MORE LIFE RESEARCH, MORE JOBS AND HIGHER INDUSTRY WAGES IN OREGON MAKE AN INCREASINGLY LARGER ECONOMIC IMPACT IN OREGON

Released in 2019

Oregon’s bioscience and R&D industry continues its steady and significant growth.

With its dedication to improving the quality of life for people around the world, Oregon’s growing life science industry continues to shine. From new and better therapies for cancer and heart disease to improvements in wound care, drug delivery methods and use of artificial intelligence to advance precision medicine, Oregon companies are at the forefront of innovation. Considering Oregon’s renowned academic and research […]

May 22nd, 2019|

NEXT: NEW BIOTECH CAMPUS COMING TO INNOVATION QUADRANT

Following the 2018 announcement of the Eastside Innovation Hub at 808 S.E. Alder in Portland, the ‘NIR Center’ is ready to break ground in the heart of Portland’s IQ at Southeast 10th and Stark, featuring research, BioSafety Level 2 laboratory space and office/collaboration elements.

Portland, Ore.  – Metro Portland and Vancouver’s Summit Development Group purchased a majority of a southeast Portland block in the Portland IQ bordered […]

April 29th, 2019|

Oregon Bio team flies in to Capitol Hill

(Portland, Ore.) – Oregon Bioscience Association participated in the 2019 BIO Legislative Day Fly-In with two of our member companies, DesignMedix and RevMedx. Biotechnology Innovation Organization (BIO) had a strong turnout with representatives from over 41 states and more than 200 biotechnology and life science industry leaders from across the U.S. attended in the District of Columbia.

Oregon Bio met with Members of Congress and staff to discuss our key legislative priorities. In meeting with our […]

April 17th, 2019|

Medintellibase150shaded

Sen. Cory Booker (D-N.J.), a 2020 presidential candidate, vowed Wednesday to create a White House office solely focused on expanding access to abortion and addressing barriers to reproductive health c [...]

New medicines, devices, and diagnostics produced by the life sciences community in California are giving clinicians better tools to fight disease and improve quality of life for patients around the wo [...]

Wisconsin Gov. Tony Evers (D) on Tuesday vowed to veto abortion restrictions the state assembly passed last week, saying that government should allow women to make their own health care decisions.  [...]

Google is changing its health care and medicine advertising policy after it came under fire for reportedly providing $150,000 in free ads to an anti-abortion group.Starting in June, any advertiser in [...]

A coalition of 23 Democrat-led states, counties and municipalities is suing the Trump administration for a final rule that protects health care providers who refuse to provide care on the basis of the [...]

Novartis, Otsuka, Pfizer and Sanofi have signed onto Verily's Project Baseline, a program aimed at mapping out a baseline for human health. [...]

Merck's Fosamax fight has lasted for years--and thanks to the U.S. Supreme Court, Merck now gets another chance to press its case. But the case also centers on a question the entire pharma indust [...]

Merck has reached a deal to acquire Peloton Therapeutics, and its Phase 3-ready kidney cancer drug, for $1.05 billion. Under the agreement announced Tuesday, Merck (NYSE: MRK) will pay the sum in cash [...]